Clinical trial
5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in…
NCT00434369 · Mast Therapeutics, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00434369 |
|---|---|
| Title | 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients |
| Official title | A Multi-Center, Open-Label, Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens |
| Lead sponsor | Mast Therapeutics, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | CoFactor (ANX-510) |
| Enrollment | 31 |
| Start date | Feb 1, 2006 |
| First posted | Feb 13, 2007 |
| Last update posted | Apr 22, 2008 |
| Countries | Argentina, Mexico, Peru, Russia, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: